Literature DB >> 19003544

Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.

Cihangir Erem1, Arif Hacihasanoglu, Orhan Deger, Mustafa Kocak, Murat Topbas.   

Abstract

The objective of this study was to estimate the prevalence of dyslipidemia as defined by NCEP ATP III criteria in the Trabzon Region of Turkey and to determine its associations with cardiovascular risk factors [hypertension (HT), body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR), and fasting serum glucose (FBG)] demographic factors (age, sex, obesity, marital status, reproductive history in women, and level of education), socioeconomic factors (household income and occupation), a family history of selected medical conditions (diabetes, HT, obesity, and cardiovascular disease), and lifestyle factors (smoking habits, physical activity, and alcohol consumption) in the adult population. In this cross-sectional survey, a sample of households was systematically selected from the central province of Trabzon city and its nine towns, namely, Akcaabat, Duzkoy, Vakfikebir, Yomra, Arakli, Of, Caykara, Surmene, and Macka. A total of 4,809 subjects (2,601 women and 2,208 men) were included in the study. Individuals older than 20 years were selected from their family health cards. Demographic and socioeconomic factors, a family history of selected medical conditions, and lifestyle factors were obtained for all participants. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) levels were measured for all subjects. The individuals included in the questionnaire were invited to the local medical centers for blood tests between 08:00 and 10:00 after 12 h of fasting. The levels of serum glucose (FBG), total cholesterol (TC), high-density cholesterol (HDL-C), low-density cholesterol (LDL-C), and trigylcerides were measured with autoanalyzer. Dyslipidemia was defined according to guidelines from the US NCEP ATP III diagnostic criteria. The ratio of TC to HDL-C was calculated. Definition and classification of HT were performed according to guidelines from the US JNC-7 report. The results obtained indicated that the age-adjusted mean values (mg/dl) of TC, LDL-C, HDL-C, [TC/HDL-C ratio], and TG were 190 +/- 0.6, 127.5 +/- 0.5, 50.3 +/- 0.3, 3.96 +/- 0.02, and 137.3 +/- 1.5, respectively. Overall, the mean levels of LDL-C, TG and TC/HDL-C ratio were higher in men than in women, whereas the mean level of HDL-C was higher in women than in men. The prevalences of hypercholesterolemia (> or =200 mg/dl), elevated LDL-C (> or =130 mg/dl), low HDL-C (<40 mg/dl), and hypertriglyceridemia (> or =150 mg/dl) were 37.5, 44.5, 21.1, and 30.4%, respectively. Prevalences of dyslipidemia were higher in men than in women, except for TC (P < 0.0001). The prevalences of high TC, LDL-C, TG, and TC/HDL-C ratio increased with age, with the highest prevalences in the 60-69-year-old group, and declined thereafter. The prevalences of high TC, LDL-C and TG, a high TC/HDL-C ratio and low HDL-C increased steadily in line with BP, BMI, WC, WHR, and FBG (P < 0.0001). Dyslipidemia was positively associated with marital status, parity, cessation of cigarette smoking and current cigarette use, and alcohol consumption, and negatively associated with the level of education, household income, and physical activity. Multiple logistic regression analysis revealed that dyslipidemia was significantly associated with the factors of age, male gender, BMI, WC (except for TC and LDL-C), HT (only for LDL-C and TG), FBG (only for LDL-C and TG), education level, cigarette smoking (only for HDL-C and TC/HDL-C ratio), alcohol consumption (except for HDL-C and TC/HDL-C ratio), occupation (especially housewives), marital status (widows and widowers), and a family history of selected medical conditions (for only TC). In conclusion, Trabzon Lipid Study data indicate that dyslipidemias are very common and an important health problem among the adult population of Trabzon. To control dyslipidemias, effective public health education and urgent measures are essential.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19003544     DOI: 10.1007/s12020-008-9100-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  53 in total

1.  Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey.

Authors:  Donna K Arnett; Paul G McGovern; David R Jacobs; Eyal Shahar; Sue Duval; Henry Blackburn; Russell V Luepker
Journal:  Am J Epidemiol       Date:  2002-11-15       Impact factor: 4.897

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 3.  Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.

Authors:  Mark C Houston; Jan Basile; William H Bestermann; Brent Egan; Daniel Lackland; Ralph G Hawkins; Michael A Moore; James Reed; Philip Rogers; Daniel Wise; Carlos M Ferrario
Journal:  Am J Med Sci       Date:  2005-06       Impact factor: 2.378

4.  Body mass index and the prevalence of hypertension and dyslipidemia.

Authors:  C D Brown; M Higgins; K A Donato; F C Rohde; R Garrison; E Obarzanek; N D Ernst; M Horan
Journal:  Obes Res       Date:  2000-12

5.  Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA.

Authors:  Christina M Berg; Lauren Lissner; Nibia Aires; Georgios Lappas; Kjell Torén; Lars Wilhelmsen; Annika Rosengren; Dag S Thelle
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2005-04

6.  Lipid profile in an adult population in Guadeloupe.

Authors:  L Foucan; P Kangambega; D K Ekouévi; J Rozet; J Bangou-Brédent
Journal:  Diabetes Metab       Date:  2000-12       Impact factor: 6.041

7.  Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China.

Authors:  Jiang He; Dongfeng Gu; Kristi Reynolds; Xigui Wu; Paul Muntner; Jiangong Zhao; Jing Chen; Donghai Liu; Jingping Mo; Paul K Whelton
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

8.  Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

Authors:  W L Haskell; E L Alderman; J M Fair; D J Maron; S F Mackey; H R Superko; P T Williams; I M Johnstone; M A Champagne; R M Krauss
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

9.  Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.

Authors:  F Azizi; F Raiszadeh; P Salehi; M Rahmani; H Emami; A Ghanbarian; R Hajipour
Journal:  Nutr Metab Cardiovasc Dis       Date:  2002-04       Impact factor: 4.222

10.  Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study.

Authors:  F Azizi; M Rahmani; A Ghanbarian; H Emami; P Salehi; P Mirmiran; N Sarbazi
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

View more
  46 in total

1.  Soy food and isoflavones are not associated with changes in serum lipids and glycohemoglobin concentrations among Japanese adults: a cohort study.

Authors:  Calistus Wilunda; Norie Sawada; Atsushi Goto; Taiki Yamaji; Motoki Iwasaki; Shoichiro Tsugane; Mitsuhiko Noda
Journal:  Eur J Nutr       Date:  2019-07-22       Impact factor: 5.614

2.  National high prevalence, and low awareness, treatment and control of dyslipidaemia among people aged 15-69 years in Mongolia in 2019.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

3.  Cholesterol and cardiovascular disease in the elderly. Facts and gaps.

Authors:  Francisco J Félix-Redondo; Maria Grau; Daniel Fernández-Bergés
Journal:  Aging Dis       Date:  2013-03-01       Impact factor: 6.745

4.  Dynamic behavior of metabolic syndrome progression: a comprehensive systematic review on recent discoveries.

Authors:  Pezhman Bagheri; Davood Khalili; Mozhgan Seif; Abbas Rezaianzadeh
Journal:  BMC Endocr Disord       Date:  2021-03-22       Impact factor: 2.763

5.  Which modifiable, non-modifiable, and socioeconomic factors have more effect on cardiovascular risk factors in overweight and obese women?

Authors:  Mansour Shahraki; Touran Shahraki; Farzad Shidfar; Hossein Ansari
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

6.  Establishment of Health Clinics as Mass Screening and Referral Systems for Chronic Non-communicable Diseases in Primary Health Care.

Authors:  Kamal Heidari; Sayyed Ali Sajjadi; Rezvaneh Hadian; Somayeh Hadi; Ramesh Hosseinkhani; Soudabeh Amini; Zahra Kiani; Ali Ajami; Reza Fadaei; Anahita Shahriari; Kasra Keramatian
Journal:  Int J Prev Med       Date:  2012-03

7.  The association between abdominal obesity and serum cholesterol level.

Authors:  Gholamreza Veghari; Mehdi Sedaghat; Siavash Maghsodlo; Samieh Banihashem; Pooneh Moharloei; Abdolhamid Angizeh; Ebrahim Tazik; Abbas Moghaddami; Hamidreza Joshaghani
Journal:  Int J Appl Basic Med Res       Date:  2015 May-Aug

8.  Prevalence and Clustering of Cardiovascular Disease Risk Factors among Tibetan Adults in China: A Population-Based Study.

Authors:  Shaopeng Xu; Zepei Jiayong; Bin Li; Hong Zhu; Hong Chang; Wei Shi; Zhengxuan Gao; Xianjia Ning; Jinghua Wang
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

9.  Obesity and risk of hypercholesterolemia in Iranian northern adults.

Authors:  Gholamreza Veghari; Mehdi Sedaghat; Hamidraza Joshghani; Samieh Banihashem; Pooneh Moharloei; Abdolhamid Angizeh; Ebrahim Tazik; Abbas Moghaddami
Journal:  ARYA Atheroscler       Date:  2013-01

10.  Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults.

Authors:  Kursat Gundogan; Fahri Bayram; Vedia Gedik; Ahmet Kaya; Ahmet Karaman; Ozgür Demir; Tevfik Sabuncu; Derya Kocer; Ramazan Coskun
Journal:  Arch Med Sci       Date:  2013-04-12       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.